日本語English简体中文 繁體中文

4595 MIZUHO MEDY CO.,LTD.ミズホメディーTSE Standard / Pharmaceuticals

0 posts

MIZUHO MEDY CO.,LTD. (4595) at a glance

Code
4595
Company
MIZUHO MEDY CO.,LTD.
Local name
ミズホメディー
Market
TSE Standard
Sector
Pharmaceuticals
Share price
¥1,686 -14.0 (-0.82%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

MIZUHO MEDY CO.,LTD. (4595) Stock Price History

MIZUHO MEDY CO.,LTD. closed at ¥1,686 on Nov 20, 2026, −2.5% over 1 month, +5.0% over 1 year.

2026-11-13 2026年12月期 第3四半期決算短信〔日本基準〕(非連結)¥1,746¥1,672Oct 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥1,746Nov 12
1-Month Low¥1,672Nov 6
1-Week Change−1.9%vs Nov 13
1-Month Change−2.5%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥97,457 today (−2.5%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved −2.5%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥1,686−14−0.82%
Nov 19 (Thu)¥1,700+2+0.12%
Nov 18 (Wed)¥1,698−19−1.11%
Nov 17 (Tue)¥1,717−18−1.04%
Nov 16 (Mon)¥1,735+16+0.93%
Nov 13 (Fri)¥1,719−27−1.55%
Nov 12 (Thu)¥1,746+42+2.46%
Nov 11 (Wed)¥1,704+0+0.00%
Nov 10 (Tue)¥1,704+16+0.95%
Nov 9 (Mon)¥1,688+16+0.96%
2026-11-13 2026年12月期 第3四半期決算短信〔日本基準〕(非連結)¥1,754¥1,672Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥1,754Sep 1
3-Month Low¥1,672Nov 6
1-Month Change−2.5%vs Oct 20
3-Month Change−1.5%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥98,539 today (−1.5%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved −1.5%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥1,686−14−0.82%
Nov 19 (Thu)¥1,700+2+0.12%
Nov 18 (Wed)¥1,698−19−1.11%
Nov 17 (Tue)¥1,717−18−1.04%
Nov 16 (Mon)¥1,735+16+0.93%
Nov 13 (Fri)¥1,719−27−1.55%
Nov 12 (Thu)¥1,746+42+2.46%
Nov 11 (Wed)¥1,704+0+0.00%
Nov 10 (Tue)¥1,704+16+0.95%
Nov 9 (Mon)¥1,688+16+0.96%
2026-11-13 2026年12月期 第3四半期決算短信〔日本基準〕(非連結)¥1,757¥1,643May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥1,757May 21
6-Month Low¥1,643Jun 29
3-Month Change−1.5%vs Aug 20
6-Month Change−3.0%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥97,008 today (−3.0%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved −3.0%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥1,686−1.5%
Oct 2026¥1,711−1.3%
Sep 2026¥1,734−0.9%
Aug 2026¥1,750+4.4%
Jul 2026¥1,677+2.1%
Jun 2026¥1,643−5.1%
May 2026¥1,731−2.3%
2026-11-13 2026年12月期 第3四半期決算短信〔日本基準〕(非連結)¥1,926¥1,606Nov 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥1,926Feb 27
52-Week Low¥1,606Nov 20
Year to Date−1.1%vs Dec 30
From 52-Week High−12.5%Feb 27

If you had invested ¥100,000 1 year ago, it would be worth ¥104,981 today (+5.0%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +13.3%, while this stock moved +5.0%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥1,686−1.5%
Oct 2026¥1,711−1.3%
Sep 2026¥1,734−0.9%
Aug 2026¥1,750+4.4%
Jul 2026¥1,677+2.1%
Jun 2026¥1,643−5.1%
May 2026¥1,731−2.3%
Apr 2026¥1,772−2.0%
Mar 2026¥1,808−6.1%
Feb 2026¥1,926+8.1%
Jan 2026¥1,782+4.5%
Dec 2025¥1,705+2.5%
Nov 2025¥1,663―
¥1,928¥1,406Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥1,928Nov 27, 2023
3-Year Low¥1,406Jun 30, 2025
Annualized Return−3.4%
Max Drawdown−27.1%

If you had invested ¥100,000 3 years ago, it would be worth ¥90,040 today (−10.0%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +67.8%, while this stock moved −10.0%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥1,686−1.1%
2025¥1,705―
¥2,058¥897Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥2,058Dec 12, 2022
5-Year Low¥897Mar 7, 2022
Annualized Return+5.8%
Max Drawdown−50.7%

If you had invested ¥100,000 5 years ago, it would be worth ¥132,599 today (+32.6%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +96.3%, while this stock moved +32.6%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥1,686−1.1%
2025¥1,705―
¥1,960¥204Jan 1, 2016Nov 20, 2026
Price1-year MA2-year MANikkei 225
All-Time High¥1,960Nov 2022
All-Time Low¥204Feb 2016
Total Change+623.2%vs Jan 2016
Annualized Return+19.9%

If you had invested ¥100,000 in Jan 2016, it would be worth ¥723,217 today (+623.2%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +236.8%, while this stock moved +623.2%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥1,686−1.1%
2025¥1,705+13.6%
2024¥1,501−4.4%
2023¥1,570−16.3%
2022¥1,875+59.0%
2021¥1,179+83.4%
2020¥643−54.2%
2019¥1,405+55.2%
2018¥905−9.7%
2017¥1,003+249.8%
2016¥287―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jan 2016). Please check the latest prices before trading.

MIZUHO MEDY CO.,LTD. (4595) financial indicators

PER
10.0
PBR
1.73
ROE
17.36%
Dividend yield
5.93%

See all financial indicators for MIZUHO MEDY CO.,LTD. (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of MIZUHO MEDY CO.,LTD. (4595)

Business overview

Mainly for in vitro diagnostics, the company conducts its own R&D with patents in view and joint research with industry, academia and government, running an integrated in-house structure for planning, development, manufacturing and sales built on ISO13485 quality management. It has a single in vitro diagnostics segment, with markets divided into hospitals and clinics, and OTC and others. In hospitals and clinics, it mainly makes and sells immunological test kits for infectious diseases to medical institutions in Japan and abroad, and since October 2018 has also handled genetic test kits for microorganisms and dedicated equipment. In OTC and others, it sells over-the-counter self-test kits for consumers to pharmacies and drugstores, and sells test kits for detecting viral diseases in fruit trees to agricultural testing stations and others.

Summarized from the annual securities report (fiscal year ended December 2025) filed on EDINET.

Position within Pharmaceuticals (79 companies)

Dividend yield5.93%No. 1 in the sector (highest first); median 2.97%
PER10.0xBelow the sector median of 16.5x (No. 8 from the lowest)
PBR1.73xBelow the sector median of 1.86x (No. 37 from the lowest)
ROE17.36%No. 4 in the sector (highest first); median 4.17%
Market cap¥32.1 bnNo. 35 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥1,9262/27
52-week low¥1,6062025/11/20
Current position25.0%Where the low is 0% and the high is 100% (close on 11/20: ¥1,686)
Year to date-1.1%No. 19 of 77 in the sector (best first)
1 year+5.0%

Based on closing prices (adjusted for stock splits, excluding dividends).

Kabutaro's ranking history

Dividend yield Top 100No. 100Current rank (all markets)

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (1).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the MIZUHO MEDY CO.,LTD. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English